fda glp-1 warning letters september 2025 news Drug ad enforcement ramps up–again FDA issued 25 warning letters

Anyone looking for a GLP-1 alternative or weight loss pill this is not that

Researchers are examining whether drugs currently approved to treat obesity and type 2 diabetes could be useful for a wider range of health challenges.

2020 global estimate and projected number of adults through 2035 with an overweight BMI [1]. Obesity is a significant independent risk factor contributing to numerous chronic conditions, including diabetes, hypertension, cardiovascular disease, and obstructive sleep apnea syndrome

Read here @AmDiabetesAssn @ADA_DiabetesPro @ADA_Pubs

Those wanting product that works beyond the surface, at the cellular level